January 17, 2011 — GE Healthcare has announced Food and Drug Administration (FDA) approval of ioflupane iodine-123 injection (DaTscan), a contrast agent for use with single-photon emission computed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback